Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis

Patent 10307371 was granted and assigned to AI Therapeutics on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+320 characters)
Article

Patent abstract

The present invention relates to methods and compositions for treating lymphangioleiomyomatosis in a human subject in need of such treatment. The methods comprise administering to the subject via inhalation an aerosol composition comprising rapamycin or a prodrug or derivative (including analog) thereof.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Henri Lichenstein0
Jonathan M. Rothberg0
Lawrence S. Melvin, Jr.0
Thomas Armer0
Edits on 7 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11744797 Rapamycin for the treatment of lymphangioleiomyomatosis
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103073710
Edits on 17 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11648199 Inhalable rapamycin formulation for treating age-related conditions
0
Edits on 9 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11491143 Inhalable rapamycin formulation for the treatment of pulmonary hypertension
0
Edits on 25 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
OrphAI Therapeutics
OrphAI Therapeutics
0
Current Assignee
OrphAI Therapeutics
OrphAI Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
103073710
Date of Patent
June 4, 2019
0
Patent Application Number
158030050
Date Filed
November 3, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=103073710
Patent Primary Examiner
‌
Melissa L Fisher
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10307371
Edits on 26 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 26 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis

Infobox
Is a
Patent
Patent
Patent applicant
OrphAI Therapeutics
OrphAI Therapeutics
Current assignee
OrphAI Therapeutics
OrphAI Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10307371
Date of patent
June 4, 2019
Patent application number
15803005
Date Filed
November 3, 2017
Patent primary examiner
‌
Melissa L Fisher

Find more entities like US Patent 10307371 Rapamycin for the treatment of lymphangioleiomyomatosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo